StatLab Medical Products has continued its expansion with the acquisition of Especialidades Médicas Myr, a Spanish histology equipment manufacturer.
The integration of Myr, with its range of equipment offerings, manufacturing capabilities, and established global distributor network, equips StatLab to expand both its portfolio and international footprint.
Headquartered near Tarragona, Spain, Myr was founded 36 years ago by Francisco (Paco) Ruiz. Myr has become a trusted supplier of high-quality histology equipment for tissue processing, embedding, sectioning, and staining, provided through an established worldwide distributor network. With this acquisition, StatLab gains an impressive manufacturing hub (pictured above) and team in Spain and unlocks new distribution channels in developing regions.
“The addition of Myr’s complementary equipment products not only diversifies our offerings but also drives momentum within key European markets powered by the Diapath and CellPath brands in our portfolio,” said Sung-Dae Hong, CEO of StatLab. “Our partnership with Myr will provide an opportunity to expand into emerging markets and fuel growth through existing channels while investing in their ability to deliver the best products and solutions. I’m excited to welcome Paco and the Myr team to StatLab and continue to invest in the strong business they’ve built.”
“The decision to join StatLab is driven by our shared commitment to meet customer needs,” said Paco Ruiz, CEO and Founder of Myr. “This is an excellent opportunity to expand Myr’s brand and business, and I’m eager for my team to work together with Dae and StatLab to leverage our products and capabilities to empower additional growth.”